The American Academy of Family Physicians and NIH identify the following clinical manifestations: Fatigue and generalized weakness Megaloblastic anemia (abnormally large, immature red blood cells) Tingling or numbness in the hands and feet (peripheral neuropathy) Difficulty walking and balance problems Cognitive disturbances including memory difficulty and confusion Mood changes, including depression and irritability Glossitis (swollen, inflamed tongue) Early symptoms such as fatigue and mild tingling are often attributed to stress, aging, or other conditions
Frequently asked questions How many doses are in a 100mg GHK-Cu vial
For tirzepatide users already managing GI side effects, iron bisglycinate may be better tolerated
Storage Instructions: Store lyophilized vials at 28C, protected from light, in the original packaging
AOD-9604 5MG BPC-157 10MG GHK-CU/BPC-157/TB-500 GLOW Blend GLOW Blend (GHK-Cu, BPC-157, TB-500) is a research-grade peptide formulation containing ~70 mg per vial and verified at 99% purity
For serious research programs, a dedicated non-frost-free laboratory freezer at stable -20C is the preferred option